Phio Pharmaceuticals Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$1.09

-0.03 (-2.68%)

As of May 16, 2:31 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,891.7% upside

Low Target $25.28

Average Target $32.61

High Target $46.79

Current Price $1.09

Current
$1.09

Target
$32.61

$25.28 $32.61 avg $46.79

Scenario Analysis

Bear Case

$25.28

2,219.3%

Low target

Base Case

$32.61

+2,891.7%

Avg target

Bull Case

$46.79

+4,192.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$4.19

-74.0% from high

52-Week Low

$0.81

+34.1% from low

Target vs 52W High

$32.61

+678.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%